Bienville Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CFLT
Confluent
CFLT
|
+$21M |
| 2 |
GitLab
GTLB
|
+$18.8M |
| 3 |
Oscar Health
OSCR
|
+$14.7M |
| 4 |
Datadog
DDOG
|
+$13.9M |
| 5 |
Flutter Entertainment
FLUT
|
+$13.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Janus Henderson B-BBB CLO ETF
JBBB
|
+$41.1M |
| 2 |
Duolingo
DUOL
|
+$12M |
| 3 |
Hims & Hers Health
HIMS
|
+$11M |
| 4 |
Rubrik
RBRK
|
+$8.06M |
| 5 |
ACV Auctions
ACVA
|
+$7.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.32% |
| 2 | Consumer Discretionary | 22.06% |
| 3 | Healthcare | 4.39% |
| 4 | Financials | 4% |
| 5 | Communication Services | 1.86% |
Similar funds
Bienville Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Bienville Capital Management held 76 positions worth $507M, up 23% from $412M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Bienville Capital Management deployed $35.9M of net new capital in Q2 2025, opening 10 new positions and adding to 22 existing holdings. Its largest new stake was Oscar Health: 989,013 shares worth $21.2M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Coupang, an estimated $5.83M trimmed.
- Bienville Capital Management's largest Q2 2025 buy was Oscar Health: 989,013 shares worth $21.2M.
- Bienville Capital Management added most to Confluent in Q2 2025, an estimated $21M increase.
- Bienville Capital Management's biggest Q2 2025 reduction was Coupang, cutting an estimated $5.83M.
- Bienville Capital Management fully exited Janus Henderson B-BBB CLO ETF in Q2 2025, selling an estimated $41.1M.
- Bienville Capital Management's ten largest holdings make up 55% of its $507M portfolio in Q2 2025.
- Bienville Capital Management opened 10 new positions and closed 8 in Q2 2025.
- Bienville Capital Management's portfolio value rose 23% quarter-over-quarter to $507M.
Based on Bienville Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.